{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:41:47Z","timestamp":1792219307302,"version":"4.4.0"},"reference-count":173,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Neurotherapeutics"],"DOI":"10.1080\/14737175.2026.2749652","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:04:26Z","timestamp":1792217066000},"page":"1-18","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Recent advances in the management of Lewy body dementia: evaluating progress and future directions"],"prefix":"10.1080","author":[{"given":"Jennifer G.","family":"Goldman","sequence":"first","affiliation":[{"name":"JPG Enterprises LLC","place":["Chicago, USA"]},{"name":"Barrow Neurological Institute","place":["Phoenix, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Wyman","sequence":"additional","affiliation":[{"name":"HealthPartners Struthers Parkinson\u2019s Center","place":["Golden Valley, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph PM.","family":"Kane","sequence":"additional","affiliation":[{"name":"Queen\u2019s University Belfast","place":["Belfast, Ireland, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004058"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-018-0058-0"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-080952"},{"issue":"3","key":"e_1_3_4_6_1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1750-3639.2009.00369.x","article-title":"The epidemiology of dementia associated with Parkinson\u2019s disease","volume":"20","author":"Aarsland D","year":"2010","unstructured":"Aarsland D, Kurz MW. The epidemiology of dementia associated with Parkinson\u2019s disease. Brain Pathol. 2010;20(3):633\u2013639.","journal-title":"Brain Pathol"},{"issue":"6","key":"e_1_3_4_7_1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years","volume":"23","author":"Hely MA","year":"2008","unstructured":"Hely MA, Reid WG, Adena MA, et al. The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov Disord. 2008;23(6):837\u2013844.","journal-title":"Mov Disord"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291713000494"},{"key":"e_1_3_4_9_1","unstructured":"Association LBD. Available from: www.lbda.org"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt251"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2010.03.007"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad241"},{"issue":"11","key":"e_1_3_4_13_1","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/mds.29590","article-title":"What\u2019s in a name? The time has come to unify Parkinson\u2019s disease and dementia with Lewy Bodies","volume":"38","author":"Weintraub D","year":"2023","unstructured":"Weintraub D. What\u2019s in a name? The time has come to unify Parkinson\u2019s disease and dementia with Lewy Bodies. Mov Disord. 2023;38(11):1977\u20131981.","journal-title":"Mov Disord"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26721"},{"issue":"2","key":"e_1_3_4_15_1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","article-title":"A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria","volume":"23","author":"Hoglinger GU","year":"2024","unstructured":"Hoglinger GU, Adler CH, Berg D, et al. A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria. Lancet Neurol. 2024;23(2):191\u2013204.","journal-title":"Lancet Neurol"},{"issue":"8","key":"e_1_3_4_16_1","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s association workgroup","volume":"20","author":"Jack CR","year":"2024","unstructured":"Jack CR, Andrews JS, Beach TG, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s association workgroup. Alzheimers Dement. 2024;20(8):5143\u20135169.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"e_1_3_4_17_1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","article-title":"A biological definition of neuronal alpha-synuclein disease: towards an integrated staging system for research","volume":"23","author":"Simuni T","year":"2024","unstructured":"Simuni T, Chahine LM, Poston K, et al. A biological definition of neuronal alpha-synuclein disease: towards an integrated staging system for research. Lancet Neurol. 2024;23(2):178\u2013190.","journal-title":"Lancet Neurol"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70470"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31822c9148"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-316844"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009323"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291720002901"},{"issue":"12","key":"e_1_3_4_23_1","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease","volume":"22","author":"Emre M","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord. 2007;22(12):1689\u20131707.","journal-title":"Mov Disord"},{"issue":"12","key":"e_1_3_4_24_1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma RB","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30(12):1591\u20131601.","journal-title":"Mov Disord"},{"issue":"2","key":"e_1_3_4_25_1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1001\/archneur.1993.00540020018011","article-title":"A clinicopathologic study of 100 cases of Parkinson\u2019s disease","volume":"50","author":"Hughes AJ","year":"1993","unstructured":"Hughes AJ, Daniel SE, Blankson S, et al. A clinicopathologic study of 100 cases of Parkinson\u2019s disease. Arch Neurol. 1993;50(2):140\u2013148.","journal-title":"Arch Neurol"},{"issue":"3","key":"e_1_3_4_26_1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/mdc3.14305","article-title":"A call for change: updating the operational definition for dementia in Parkinson\u2019s disease","volume":"12","author":"Kulisevsky J","year":"2025","unstructured":"Kulisevsky J, Litvan I, Weintraub D, et al. A call for change: updating the operational definition for dementia in Parkinson\u2019s disease. Mov Disord Clin Pract. 2025;12(3):296\u2013301.","journal-title":"Mov Disord Clin Pract"},{"issue":"3","key":"e_1_3_4_27_1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society task force guidelines","volume":"27","author":"Litvan I","year":"2012","unstructured":"Litvan I, Goldman JG, Tr\u00f6ster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society task force guidelines. Mov Disord. 2012;27(3):349\u2013356.","journal-title":"Mov Disord"},{"issue":"4","key":"e_1_3_4_28_1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/mds.27323","article-title":"Evolution of diagnostic criteria and assessments for Parkinson\u2019s disease mild cognitive impairment","volume":"33","author":"Goldman JG","year":"2018","unstructured":"Goldman JG, Holden SK, Litvan I, et al. Evolution of diagnostic criteria and assessments for Parkinson\u2019s disease mild cognitive impairment. Mov Disord. 2018;33(4):503\u2013510.","journal-title":"Mov Disord"},{"issue":"5","key":"e_1_3_4_29_1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/mds.27335","article-title":"Selection of normative group affects rates of mild cognitive impairment in Parkinson\u2019s disease","volume":"33","author":"Wyman-Chick KA","year":"2018","unstructured":"Wyman-Chick KA, Martin PK, Weintraub D, et al. Selection of normative group affects rates of mild cognitive impairment in Parkinson\u2019s disease. Mov Disord. 2018;33(5):839\u2013843.","journal-title":"Mov Disord"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0000000000000007"},{"issue":"1","key":"e_1_3_4_31_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/mds.29649","article-title":"Subjective cognitive complaints in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"39","author":"Siciliano M","year":"2024","unstructured":"Siciliano M, Tessitore A, Morgante F, et al. Subjective cognitive complaints in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord. 2024;39(1):17\u201328.","journal-title":"Mov Disord"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-020-00983-7"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-024-02796-w"},{"issue":"2","key":"e_1_3_4_34_1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/mds.27233","article-title":"Global scales for cognitive screening in Parkinson\u2019s disease: critique and recommendations","volume":"33","author":"Skorvanek M","year":"2018","unstructured":"Skorvanek M, Goldman JG, Jahanshahi M, et al. Global scales for cognitive screening in Parkinson\u2019s disease: critique and recommendations. Mov Disord. 2018;33(2):208\u2013218.","journal-title":"Mov Disord"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0000000000000414"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(25)00314-X"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126371"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.70296"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1395413"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005122"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011454"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291718000995"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003512"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120540"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-024-06631-y"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-8892-x"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000004627"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-160435"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10090616"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cnp.2025.06.008"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14584"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2025-336935"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad192"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2023.119908"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI172460"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.4103\/NRR.NRR-D-24-01348"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells14161272"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200878"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-020-02160-8"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209656"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214614"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-023-02663-0"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13799"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214346"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-025-02195-6"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.70291"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.70158"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nlag048"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.111005"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.92775"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209418"},{"issue":"9","key":"e_1_3_4_72_1","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/mds.30238","article-title":"Plasma phosphorylated Tau181 as a biomarker for Alzheimer\u2019s disease Co-pathology in Lewy Body disease","volume":"40","author":"Ye R","year":"2025","unstructured":"Ye R, Kivis\u00e4kk P, Goodheart A, et al. Plasma phosphorylated Tau181 as a biomarker for Alzheimer\u2019s disease Co-pathology in Lewy Body disease. Mov Disord. 2025;40(9):1930\u20131939.","journal-title":"Mov Disord"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.27003"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207755"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70788"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaf003"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.30181"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2026.108265"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad072"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz111"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00123"},{"issue":"10","key":"e_1_3_4_82_1","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1002\/alz.13357","article-title":"Longitudinal motor decline in dementia with Lewy bodies, Parkinson disease dementia, and Alzheimer\u2019s dementia in a community autopsy cohort","volume":"19","author":"Choudhury P","year":"2023","unstructured":"Choudhury P, Zhang N, Adler CH, et al. Longitudinal motor decline in dementia with Lewy bodies, Parkinson disease dementia, and Alzheimer\u2019s dementia in a community autopsy cohort. Alzheimers Dement. 2023;19(10):4377\u20134387.","journal-title":"Alzheimers Dement"},{"issue":"8","key":"e_1_3_4_83_1","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/mds.10455","article-title":"Extrapyramidal features in Parkinson\u2019s disease with and without dementia and dementia with Lewy bodies: a cross-sectional comparative study","volume":"18","author":"Burn DJ","year":"2003","unstructured":"Burn DJ, Rowan EN, Minett T, et al. Extrapyramidal features in Parkinson\u2019s disease with and without dementia and dementia with Lewy bodies: a cross-sectional comparative study. Mov Disord. 2003;18(8):884\u2013889.","journal-title":"Mov Disord"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201964"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1177\/0891988717701001"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2019.04.020"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209699"},{"issue":"4","key":"e_1_3_4_88_1","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/13854040500376831","article-title":"Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer\u2019s disease","volume":"20","author":"Ferman TJ","year":"2006","unstructured":"Ferman TJ, Smith GE, Boeve BF, et al. Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer\u2019s disease. Clin Neuropsychol. 2006;20(4):623\u2013636.","journal-title":"Clin Neuropsychol"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14450"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209499"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291725100895"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105762"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/s44400-025-00022-2"},{"issue":"10","key":"e_1_3_4_94_1","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/mds.29918","article-title":"Risk of dementia in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"39","author":"Gibson LL","year":"2024","unstructured":"Gibson LL, Weintraub D, Lemmen R, et al. Risk of dementia in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord. 2024;39(10):1697\u20131709.","journal-title":"Mov Disord"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00280-3"},{"issue":"10","key":"e_1_3_4_96_1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/mds.20527","article-title":"A systematic review of prevalence studies of dementia in Parkinson\u2019s disease","volume":"20","author":"Aarsland D","year":"2005","unstructured":"Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinson\u2019s disease. Mov Disord. 2005;20(10):1255\u20131263.","journal-title":"Mov Disord"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.3.387"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11921-w"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.3758\/s13415-025-01343-8"},{"issue":"2","key":"e_1_3_4_100_1","doi-asserted-by":"crossref","first-page":"e16108","DOI":"10.1111\/ene.16108","article-title":"Cholinergic basal forebrain system degeneration underlies postural instability\/gait difficulty and attention impairment in Parkinson\u2019s disease","volume":"31","author":"Wu C","year":"2024","unstructured":"Wu C, Wu H, Zhou C, et al. Cholinergic basal forebrain system degeneration underlies postural instability\/gait difficulty and attention impairment in Parkinson\u2019s disease. Eur J Neurol. 2024;31(2):e16108.","journal-title":"Eur J Neurol"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28932"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-022-06031-w"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz350"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214036"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaf105"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e30175"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.30067"},{"key":"e_1_3_4_108_1","doi-asserted-by":"crossref","unstructured":"Beach TG Serrano GE Driver-Dunckley ED et al. Parkinson disease neuropathological comorbidities: prevalences from younger-old to older-old with comparison to non-demented non-parkinsonian subjects. 2025.","DOI":"10.1101\/2025.01.13.25319971"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-200395"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-325668"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)30291-5"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.55730\/1300-0144.5593"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1002\/gps.5839"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.3233\/ADR-230064"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-022-00417-w"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012450"},{"issue":"20","key":"e_1_3_4_117_1","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1001\/jama.1997.03550200063033","article-title":"Evidence-based disease management","volume":"278","author":"Ellrodt G","year":"1997","unstructured":"Ellrodt G, Cook DJ, Lee J, et al. Evidence-based disease management. JAMA. 1997;278(20):1687\u20131692.","journal-title":"JAMA"},{"issue":"1","key":"e_1_3_4_118_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12875-017-0652-y","article-title":"The diagnostic pathway of Parkinson\u2019s disease: a cross-sectional survey study of factors influencing patient dissatisfaction","volume":"18","author":"Plouvier AO","year":"2017","unstructured":"Plouvier AO, Olde Hartman TC, De Bont OA, et al. The diagnostic pathway of Parkinson\u2019s disease: a cross-sectional survey study of factors influencing patient dissatisfaction. BMC Fam Pract. 2017;18(1):83.","journal-title":"BMC Fam Pract"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0000000000000459"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1111\/hex.70391"},{"issue":"2","key":"e_1_3_4_121_1","doi-asserted-by":"crossref","first-page":"e14539","DOI":"10.1002\/alz.14539","article-title":"Usage patterns of cognitive assessments during medicare\u2019s annual wellness visit: a national survey","volume":"21","author":"Liu Y","year":"2025","unstructured":"Liu Y, Ozawa T, Mattke S. Usage patterns of cognitive assessments during medicare\u2019s annual wellness visit: a national survey. Alzheimers Dement. 2025;21(2):e14539.","journal-title":"Alzheimers Dement"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002001"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-230285"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadm.2015.05.004"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2025.02.011"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-018-0350-6"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00786-8"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28282"},{"key":"e_1_3_4_129_1","unstructured":"DIAMOND-LEWY Management Toolkit. [cited 2026 Apr 4]. Available from: https:\/\/research.ncl.ac.uk\/diamondlewy\/managementtoolkit\/"},{"key":"e_1_3_4_130_1","unstructured":"The U.S. Based diamond lewy\u2122 management toolkit: lewy body dementia association. [cited 2026 Apr 4]. Available from: https:\/\/lbda.org\/diamond-lewy"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1002\/gps.4609"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.1002\/gps.4948"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2025.2450668"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2024.12.008"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30153-X"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068718"},{"issue":"3","key":"e_1_3_4_137_1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/14728214.2023.2244425","article-title":"Emerging drugs for dementia with Lewy Bodies: a review of phase II & III trials","volume":"28","author":"Tolea MI","year":"2023","unstructured":"Tolea MI, Ezzeddine R, Camacho S, et al. Emerging drugs for dementia with Lewy Bodies: a review of phase II & III trials. Expert Opin Emerg Drugs. 2023;28(3):167\u2013180.","journal-title":"Expert Opin Emerg Drugs"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00856-7"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2025.2562151"},{"issue":"10","key":"e_1_3_4_140_1","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1474-4422(10)70194-0","article-title":"Memantine for patients with Parkinson\u2019s disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Emre M","year":"2010","unstructured":"Emre M, Tsolaki M, Bonuccelli U, et al. Memantine for patients with Parkinson\u2019s disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2010;9(10):969\u2013977.","journal-title":"Lancet Neurol"},{"issue":"7","key":"e_1_3_4_141_1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1474-4422(09)70146-2","article-title":"Memantine in patients with Parkinson\u2019s disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial","volume":"8","author":"Aarsland D","year":"2009","unstructured":"Aarsland D, Ballard C, Walker Z, et al. Memantine in patients with Parkinson\u2019s disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet Neurol. 2009;8(7):613\u2013618.","journal-title":"Lancet Neurol"},{"key":"e_1_3_4_142_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22322"},{"issue":"9","key":"e_1_3_4_143_1","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/jnnp.2004.052332","article-title":"The role of levodopa in the management of dementia with Lewy bodies","volume":"76","author":"Molloy S","year":"2005","unstructured":"Molloy S, McKeith IG, O\u2019Brien JT, et al. The role of levodopa in the management of dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2005;76(9):1200\u20131203.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"e_1_3_4_144_1","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/jnnp.2006.098079","article-title":"Effect of levodopa on cognitive function in Parkinson\u2019s disease with and without dementia and dementia with Lewy bodies","volume":"77","author":"Molloy SA","year":"2006","unstructured":"Molloy SA, Rowan EN, O\u2019Brien JT, et al. Effect of levodopa on cognitive function in Parkinson\u2019s disease with and without dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2006;77(12):1323\u20131328.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_4_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2019.12.005"},{"key":"e_1_3_4_146_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2023.1835"},{"key":"e_1_3_4_147_1","doi-asserted-by":"publisher","DOI":"10.1080\/13607863.2022.2032601"},{"key":"e_1_3_4_148_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12814"},{"key":"e_1_3_4_149_1","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000001173"},{"issue":"3","key":"e_1_3_4_150_1","doi-asserted-by":"crossref","first-page":"e70134","DOI":"10.1002\/trc2.70134","article-title":"A common outcome set for trials in dementia with Lewy bodies (DLB COS)","volume":"11","author":"Kane JP","year":"2025","unstructured":"Kane JP, Fitzpatrick RL, Betzhold S, et al. A common outcome set for trials in dementia with Lewy bodies (DLB COS). Alzheimer\u2019s Dementia Transl Res Clin Intervent. 2025;11(3):e70134.","journal-title":"Alzheimer\u2019s Dementia Transl Res Clin Intervent"},{"key":"e_1_3_4_151_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.71004"},{"issue":"8","key":"e_1_3_4_152_1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jamaneurol.2025.1687","article-title":"Ambroxol as a treatment for Parkinson disease dementia: a randomized clinical trial","volume":"82","author":"Silveira CR","year":"2025","unstructured":"Silveira CR, Coleman KK, Borron K, et al. Ambroxol as a treatment for Parkinson disease dementia: a randomized clinical trial. JAMA Neurol. 2025;82(8):797\u2013807.","journal-title":"JAMA Neurol"},{"key":"e_1_3_4_153_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1163184"},{"key":"e_1_3_4_154_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-024-01023-0"},{"key":"e_1_3_4_155_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291717003257"},{"key":"e_1_3_4_156_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brs.2020.04.010"},{"key":"e_1_3_4_157_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2025.104510"},{"key":"e_1_3_4_158_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dscb.2025.100187"},{"key":"e_1_3_4_159_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2020.1771184"},{"key":"e_1_3_4_160_1","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-230117"},{"key":"e_1_3_4_161_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00703-5"},{"key":"e_1_3_4_162_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00299-w"},{"key":"e_1_3_4_163_1","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-230257"},{"key":"e_1_3_4_164_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2023.3664"},{"key":"e_1_3_4_165_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.4222"},{"key":"e_1_3_4_166_1","doi-asserted-by":"publisher","DOI":"10.1038\/s44400-025-00050-y"},{"key":"e_1_3_4_167_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.30110"},{"key":"e_1_3_4_168_1","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.70059"},{"key":"e_1_3_4_169_1","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12235"},{"key":"e_1_3_4_170_1","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-225068"},{"key":"e_1_3_4_171_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-00907-2"},{"key":"e_1_3_4_172_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70217"},{"key":"e_1_3_4_173_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-025-01760-4"},{"key":"e_1_3_4_174_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-023-00467-8"},{"issue":"10","key":"e_1_3_4_175_1","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/mds.30007","article-title":"International Parkinson and Movement Disorder Society viewpoint on biological frameworks of Parkinson\u2019s disease: current status and future directions","volume":"39","author":"Kalia LV","year":"2024","unstructured":"Kalia LV, Berg D, Kordower JH, et al. International Parkinson and Movement Disorder Society viewpoint on biological frameworks of Parkinson\u2019s disease: current status and future directions. Mov Disord. 2024;39(10):1710\u20131715.","journal-title":"Mov Disord"}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2026.2749652","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14737175.2026.2749652","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2026.2749652","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:04:32Z","timestamp":1792217072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737175.2026.2749652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":173,"alternative-id":["10.1080\/14737175.2026.2749652"],"URL":"https:\/\/doi.org\/10.1080\/14737175.2026.2749652","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"value":"1473-7175","type":"print"},{"value":"1744-8360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-06-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}